These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 14626524)

  • 1. Unraveling the mysteries of syndrome X. As the number of Americans with insulin resistance grows, pharmacists can help patients prevent the onset of type 2 diabetes and cardiovascular disease.
    Campbell RK
    J Am Pharm Assoc (2003); 2003; 43(5 Suppl 1):S32-3. PubMed ID: 14626524
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epidemiology of the insulin resistance syndrome.
    Meigs JB
    Curr Diab Rep; 2003 Feb; 3(1):73-9. PubMed ID: 12643149
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Counseling patients with type 2 diabetes and insulin resistance in the outpatient setting.
    Campbell RK; White J
    Diabetes Educ; 2002; 28(6):938-43, 947-50, 952-4 passim. PubMed ID: 12526635
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Should the insulin resistance syndrome be treated in the elderly?
    Grant RW; Meigs JB
    Drugs Aging; 2004; 21(3):141-51. PubMed ID: 14979733
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identifying insulin resistance is important to prevent development of glucose intolerance and the metabolic syndrome.
    Khoo CL
    Med J Aust; 2007 Mar; 186(5):269-70; author reply 271-2. PubMed ID: 17391094
    [No Abstract]   [Full Text] [Related]  

  • 6. Preventing and managing cardiometabolic risk: the logic for intervention.
    Pereira MA; Kottke TE; Jordan C; O'Connor PJ; Pronk NP; Carreón R
    Int J Environ Res Public Health; 2009 Oct; 6(10):2568-84. PubMed ID: 20054455
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metabolic syndrome: demographic features, etiology, and clinical management.
    Wyne KL
    Curr Atheroscler Rep; 2005 Sep; 7(5):381-8. PubMed ID: 16105482
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Metabolic syndrome, insulin resistance and cardiovascular disease in type-1 diabetes mellitus].
    Rodrigues TC; Canani LH; Gross JL
    Arq Bras Cardiol; 2010 Jan; 94(1):134-9. PubMed ID: 20414537
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nurse health and lifestyle modification versus standard care in 40 to 70 year old regional adults: study protocol of the Management to Optimise Diabetes and mEtabolic syndrome Risk reduction via Nurse-led intervention (MODERN) randomized controlled trial.
    Carrington MJ; Zimmet P
    BMC Health Serv Res; 2017 Dec; 17(1):813. PubMed ID: 29212477
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessing and Managing the Metabolic Syndrome in Children and Adolescents.
    DeBoer MD
    Nutrients; 2019 Aug; 11(8):. PubMed ID: 31382417
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolic syndrome.
    Vitale C; Marazzi G; Volterrani M; Aloisio A; Rosano G; Fini M
    Minerva Med; 2006 Jun; 97(3):219-29. PubMed ID: 16855517
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Effectiveness of Pharmacist Interventions on Cardiovascular Risk in Adult Patients with Type 2 Diabetes: The Multicentre Randomized Controlled R
    Al Hamarneh YN; Hemmelgarn BR; Hassan I; Jones CA; Tsuyuki RT
    Can J Diabetes; 2017 Dec; 41(6):580-586. PubMed ID: 28965748
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metabolic syndrome.
    Gogia A; Agarwal PK
    Indian J Med Sci; 2006 Feb; 60(2):72-81. PubMed ID: 16505579
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Drug-induced obesity and its metabolic consequences: a review with a focus on mechanisms and possible therapeutic options.
    Verhaegen AA; Van Gaal LF
    J Endocrinol Invest; 2017 Nov; 40(11):1165-1174. PubMed ID: 28660606
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Secondary diabetes associated with principal endocrinopathies: the impact of new treatment modalities.
    Resmini E; Minuto F; Colao A; Ferone D
    Acta Diabetol; 2009 Jun; 46(2):85-95. PubMed ID: 19322513
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The pharmacological management of metabolic syndrome.
    Rask Larsen J; Dima L; Correll CU; Manu P
    Expert Rev Clin Pharmacol; 2018 Apr; 11(4):397-410. PubMed ID: 29345505
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nuts and Dried Fruits: An Update of Their Beneficial Effects on Type 2 Diabetes.
    Hernández-Alonso P; Camacho-Barcia L; Bulló M; Salas-Salvadó J
    Nutrients; 2017 Jun; 9(7):. PubMed ID: 28657613
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Components of the metabolic syndrome among a sample of overweight and obese Costa Rican schoolchildren.
    Holst-Schumacher I; Nuñez-Rivas H; Monge-Rojas R; Barrantes-Santamaría M
    Food Nutr Bull; 2009 Jun; 30(2):161-70. PubMed ID: 19689095
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Metabolic syndrome: only a list of risk factors or an independent disease pattern?].
    Holzgreve H
    MMW Fortschr Med; 2008 Aug; 150(32-35):47-8. PubMed ID: 19006883
    [No Abstract]   [Full Text] [Related]  

  • 20. Clinical implications of the metabolic syndrome.
    Ceska R
    Diab Vasc Dis Res; 2007 Sep; 4 Suppl 3():S2-4. PubMed ID: 17935057
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.